Science Current Events | Science News | Brightsurf.com
 

Degenerative Blindness Current Events | Degenerative Blindness News | 10
Page 10 of 13 | 306 Results
Previous0304050607080910111213   Next   
Sort By: Page Views | Date
Progress toward a more targeted treatment of Alzheimer's disease
Scientists from the Flanders Interuniversity Institute for Biotechnology (VIB) connected with the Catholic University of Leuven have shed a little more light on Alzheimer's disease. They've gone deeply into the operation of ?-secretase, a crucial factor in the origin of the disease. Their research... view more (2005-01-31)

Childhood vaccination may protect adult eyes
Childhood vaccination for the rubella virus may have also almost entirely eliminated an inflammatory eye disease from the U.S.-born population, according to a study by researchers at the University of Illinois at Chicago.   view more (2007-09-20)

Infectious heart disease death rates rising again say scientists
Infectious heart disease is still a major killer in spite of improvements in health care, but the way the disease develops has changed so much since its discovery that nineteenth century doctors would not recognize it.   view more (2008-09-11)

New hope for Huntington's sufferers
A major breakthrough in the understanding and potential treatment of Huntington's disease has been made by scientists at the University of Leeds.   view more (2007-08-23)

Researchers discover architecture for fundamental processes of life
A team of Canadian researchers has completed a massive survey of the network of protein complexes that orchestrate the fundamental processes of life.   view more (2008-05-14)

'Twinkle' eye test could improve AMD diagnosis
Scientists at UCL (University College London) have developed a more reliable test for detecting vision loss in people with age-related macular disease (AMD), the leading cause of blindness in the UK and US. The method, which centres on a visual illusion, could lead to earlier self-diagnosis of... view more (2007-10-25)

Groundbreaking study tackles costly disease - Type 2 diabetes -affecting millions of people worldwide.
NEWCASTLE University scientists have had a major breakthrough in tackling Type 2 diabetes, which has become a huge worldwide concern and is costing billions of pounds to treat each year. A groundbreaking study, carried out in collaboration with Liverpool University, has found Type 2 diabetes... view more (2001-09-10)

New angiogenesis finding may help fight cancer growth
A researcher at the University of Wisconsin-Madison School of Medicine and Public Health has discovered a new part of the complicated mechanism that governs the formation of blood vessels, or angiogenesis.   view more (2006-09-29)

Study confirms intensive treatment of diabetic patients significantly reduces heart disease
New study results confirm, for the first time, that intensive treatment of diabetic patients results in a significantly lower risk of heart disease. In fact, it can cut the risk of cardiovascular disease nearly in half.   view more (2005-06-17)

Disease-causing protein protects against nerve damage in Parkinson's disease
Researchers at UT Southwestern Medical Center have discovered that a protein associated with causing neurodegenerative conditions may, when appearing in normal amounts, actually protect against neurodegeneration.   view more (2005-11-04)

Forsyth scientists discover early key to regeneration
Science may be one step closer to understanding how a limb can be grown or a spinal cord can be repaired. Scientists at The Forsyth Institute have discovered that some cells have to die for regeneration to occur.   view more (2006-12-13)

Promising early evidence of the superior benefits of drug therapy for diabetic eye disease
A JDRF collaboration between Johns Hopkins researchers and Genentech has shown that a drug for the treatment of diabetic eye disease has performed better in clinical trials than the current standard treatment using laser surgery.   view more (2008-04-30)

Mayo discovers link between Huntington's and abnormal cholesterol levels in brain
Mayo Clinic researchers have discovered a protein interaction that may explain how the deadly Huntington's disease affects the brain.   view more (2006-12-04)

Carnegie Mellon scientists offer explanation for 'face blindness'
For the first time, scientists have been able to map the disruption in neural circuitry of people suffering from congenital prosopagnosia, sometimes known as face blindness, and have been able to offer a biological explanation for this intriguing disorder.   view more (2008-11-26)

Brain plays key role in regulating bone density
The brain plays an important role in the maintenance of proper bone density, researchers at the Hebrew University of Jerusalem have revealed.   view more (2005-08-25)

Study Highlights Need For UK Childhood Screening For Amblyopia (pp 597, 621)
Authors of a study in this week's issue of THE LANCET highlight how the risk of visual loss in the normal eye for individuals with one lazy eye (amblyopia) is greater than previously thought, strengthening the need for effective screening programmes to detect amblyopia in early childhood. Monocular... view more (2002-08-21)

Young Children Main Priority For Prevention Of Blinding Trachoma (pp 181, 198, 223)
Targeting antibiotics at young children and improving hygiene are key to eradicating a potentially blinding bacterial infection that affects around 150 million people worldwide, according to authors of a study in this week's issue of THE LANCET. Trachoma is a preventable blinding condition that... view more (2003-07-16)

Illuminating Alzheimer's: Research sheds light on creatine's presence in brain
Alzheimer's disease is one of the most hauntingly destructive maladies to wreak havoc on humans. It robs children of parents and spouses of each other-with lifetimes of memories lost forever behind blank stares.    view more (2005-12-22)

Chemotherapy causes delayed severe neural damage
Cancer treatment with chemotherapeutic agents is often associated with delayed adverse neurological consequences - an occurrence often referred to as "chemobrain" - that may compromise the quality of life of a proportion of cancer survivors.   view more (2008-04-22)

Diabetes Research Centre Opens at Plymouth
The research programme will be conducted from brand new offices in the Department of Child Health at Derriford Hospital, which will be officially opened on Wednesday 28 July at 1pm. The Centre comprises a laboratory for the preparation and cold storage of samples and an office. It has been built... view more (1999-07-27)

Antibody therapy prevents type 1 diabetes in mice
University of Pittsburgh investigators have successfully prevented the onset of type 1 diabetes in mice prone to developing the disease using an antibody against a receptor on the surface of immune T-cells. According to the investigators.   view more (2007-01-09)

UCSF surgeon develops new spinal surgery technique
Called a lateral paramedian transpedicular approach, the technique uses advances in spinal instrumentation and reconstructive strategies to provide a direct approach to the removal of cervical spinal tumors with minimal, or no, neural manipulation.   view more (2005-11-07)

Key component of debilitating lung disease identified
For the first time, researchers have demonstrated a close correlation between the decline in a key component of the lung's antioxidant defense system and the progression of chronic obstructive pulmonary disease (COPD) in humans.   view more (2008-09-12)

Type 1 diabetes triggered by 'lazy' regulatory T-cells: McGill researchers
A research team led by Dr. Ciriaco A. Piccirillo of McGill University's Department of Microbiology and Immunology has discovered that in some individuals, the specialized immunoregulatory T-cells that regulate the body's autoimmune reactions may lose their effectiveness and become "lazy"... view more (2008-01-16)

Migragen Appoints Dr. Lucio A.A. Van Rooijen As President And Chief Executive Officer
Tuebingen, September 4, 2002 "¦"¦. Migragen AG is pleased to announce the appointment of Dr. Lucio A.A. van Rooijen as President and Chief Executive Officer with effect from 1st September. Migragen is an emerging biopharmaceutical company focused in the areas of CNS injury, degenerative... view more (2002-09-05)
Page 10 of 13 | 306 Results
Previous0304050607080910111213   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com